Across TCGA pan-cancer cohorts, PSLNR RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated PSLNR data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher PSLNR RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PSLNR expression acts as an unfavorable survival marker, although some lineages such as CHOL and CESC show a favorable association.
UCEC, KICH, and STAD are the cancer types where PSLNR RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.